Matching trials
1,853 results
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MONOIIndependent statistical analysis of the MONOI phase 3 trial of darunavir boosted with ritonavir in HIV-1 infected patients, covering the randomized design, virological success endpoint, planned statistical analysis, and interpretation.
- Montelukast in Perennial Allergic Rhinitis – 2001-2002 Study (0476-246): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00974571).
- Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: Complete Statistical AnalysisIndependent statistical analysis of Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MOUNTAINEER-03Independent statistical analysis of the phase 3 MOUNTAINEER-03 trial evaluating tucatinib with trastuzumab and mFOLFOX6 versus standard-of-care treatment in first-line HER2+ metastatic colorectal cancer.
- MOVEIndependent statistical analysis of Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels…
- MOVe-AHEADIndependent statistical analysis of the phase 3 MOVe-AHEAD trial of molnupiravir for prevention of Coronavirus Disease (COVID-19) in adults, including endpoint definitions, score-based confidence intervals, reported results, safety, and statistical interpretation.
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180634).
- MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780463).
- MRC CR07An educational statistical analysis of MRC CR07 (NCT00003422), a randomized phase 3 trial comparing radiation therapy before surgery with chemotherapy plus radiation after surgery in surgically removable rectal cancer.
- Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care: Complete Statistical AnalysisIndependent statistical analysis of Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only…
- MVA-BN-RSV Vaccine Trial: Complete Statistical AnalysisIndependent statistical analysis of MVA-BN-RSV Vaccine Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05238025).
- MVP#1Independent statistical analysis of Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515177).
- Mylan Insulin Aspart Study: Complete Statistical AnalysisIndependent statistical analysis of Mylan Insulin Aspart Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03760068).
- myOpportunITy2Independent statistical analysis of A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- myOpportunITy3Independent statistical analysis of A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00248625).
- NABIS:HIIRIndependent statistical analysis of Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178711).
- NADIAAn independent statistical analysis of the randomized phase 3 NADIA trial evaluating darunavir/ritonavir and dolutegravir-based treatment strategies in people with human immunodeficiency virus, including its factorial design, 48-week viral-load endpoint, and planned…
- NALAIndependent statistical analysis of NALA, a randomized phase 3 trial of neratinib plus capecitabine versus lapatinib plus capecitabine in HER2+ metastatic breast cancer after two or more prior HER2-directed regimens.
- NATALEEA detailed statistical analysis of the phase 3 NATALEE trial evaluating ribociclib with endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer, including trial design, endpoint methodology, statistical interpretation,…
- NATRONIndependent statistical analysis of A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NAVIGATE ESUSIndependent statistical analysis of NAVIGATE ESUS, a randomized phase 3 trial comparing rivaroxaban with aspirin in patients with recent embolic stroke of undetermined source, including time-to-event methods, primary and secondary results, safety,…
- NAVIGATORIndependent statistical analysis of the phase 3 NAVIGATOR trial (NCT03347279) of tezepelumab 210mg Q4W versus placebo in severe uncontrolled asthma: negative binomial exacerbation rate ratios, mixed-model secondary endpoints, safety and interpretation.
- NCCTG N9831Independent statistical analysis of NCCTG N9831, a randomized phase 3 trial evaluating doxorubicin, cyclophosphamide, and paclitaxel with or without trastuzumab in women with HER2-positive node-positive or high-risk node-negative breast cancer.
- NefigardIndependent statistical analysis of Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Neo ALTTOIndependent statistical analysis of Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553358).
- Neo-AEGISIndependent statistical analysis of the Neo-AEGIS phase 3 randomized trial evaluating perioperative chemotherapy versus chemoradiotherapy approaches in oesophageal and oesophago-gastric junction adenocarcinoma.
- NeoALTTOIndependent statistical analysis of the phase 3 NeoALTTO trial of lapatinib and trastuzumab in neoplasms of the breast, including pathological complete response, event-free survival, overall survival, landmark analyses, methodology, and interpretation.
- NETTAn independent statistical analysis of the National Emphysema Treatment Trial (NETT), a randomized phase 3 study of lung volume reduction surgery in emphysema and related obstructive lung disease.
- NETTER-1Independent statistical analysis of the phase 3 NETTER-1 trial comparing 177Lu-DOTA0-Tyr3-Octreotate with Octreotide LAR in patients with inoperable, progressive, somatostatin receptor positive midgut carcinoid tumours.
- Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00677690).
- New Treatment for Alcohol and Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of New Treatment for Alcohol and Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182766).
- NEXT2Independent statistical analysis of Efficacy of Esomeprazole in Patients With Frequent Heartburn: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01370538).
- NextCOVEComplete statistical analysis of the phase 3 NextCOVE trial comparing mRNA-1283 with mRNA-1273 for prevention of COVID-19 in participants aged 12 years and older, including non-inferiority methodology, antibody endpoints, COVID-19 efficacy, safety,…
- NGAM-05Independent statistical analysis of High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313507).
- NIAGARAIndependent statistical analysis of Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NIMBLEIndependent statistical analysis of the phase 3 NIMBLE trial (NCT04718389) comparing depemokimab with mepolizumab or benralizumab in severe eosinophilic asthma, including the negative binomial exacerbation rate ratio, non-inferiority logic, ANCOVA secondary endpoints…
- NIMBUSIndependent statistical analysis of A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple…
- Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1): Complete Statistical AnalysisIndependent statistical analysis of Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nitrous Oxide for External Cephalic Version: Complete Statistical AnalysisIndependent statistical analysis of Nitrous Oxide for External Cephalic Version: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03502915).
- NIXIndependent statistical analysis of the phase 3 NIX trial evaluating bedaquiline, PA-824, and linezolid in participants with drug-resistant pulmonary tuberculosis, including trial design, the bacteriologic and clinical treatment-failure endpoint, planned statistical interpretation,…
- No-POPPYIndependent statistical analysis of Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NO16968Independent statistical analysis of NO16968 (NCT00069121), a randomized phase 3 trial of capecitabine plus oxaliplatin versus 5-FU/LV in colorectal cancer, including disease-free survival, relapse-free survival, overall survival, statistical methodology, and interpretation.
- NOA-04Independent statistical analysis of NOA-04, a randomized phase 3 study of sequential radiochemotherapy with PCV or temozolomide in anaplastic glioma.
- NOAHComplete statistical analysis of the NOAH phase 3 trial of edoxaban versus ASA or placebo in patients with atrial high rate episodes, including trial design, time-to-event methodology, primary and secondary results, safety,…
- NOCTIndependent statistical analysis of Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults: primary endpoint…
- NOH303Independent statistical analysis of Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…